2m 2m 2m 2m 2m 2m 2m
CONTEXT THERAP (CNTX)
NASDAQ
$0.23-$0.003 (-1.47%)
Price as of Oct 22, 2026 7:51 PM EDT- $21.3MMarket Cap
- -80.88%1-Year Change
- BiotechnologyIndustry
CONTEXT THERAP (CNTX)
$0.23-$0.003 (-1.47%)
CNTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.23 | ||
Change | -$0.01 (-5.09%) | ||
Open | $0.25 | ||
High | $0.25 | ||
Low | $0.22 | ||
Previous Close | $0.24 | ||
Volume | 1,167,125 | ||
30-Day Average Volume | 983,118 | ||
1-Week Change | -9.47% | ||
1-Month Change | -38.23% | ||
1-Year Change | -80.88% | ||
3-Year Change | -79.52% | ||
5-Year Change | -96.25% | ||
Fundamentals | |||
Shares Outstanding | 91.9M | ||
Total Assets | $46.1M | ||
Market Cap | $21.3M | ||
Enterprise Value | -$21.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$14.6M | ||
Free Cash Flow | -$7.0M | ||
EBIT | -$14.6M | ||
EBITDA | -$14.6M | ||
Net Working Capital | $37.9M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue